Abstract
In press
In the course of the work to study the pathopsychological features of emotional and cognitive disorders in the structure of post-COVID syndrome, a comprehensive clinical-psychopathological and psychodiagnostic examination of 167 patients both sexes (85 women and 82 men) with non-psychotic mental disorders against the background of COVID was conducted. It has been established that the dominance in the structure of mental disorders against the background of COVID-19 is complaints of decreased mood, apathy, inactivity, loss of a sense of joy and pleasure, feelings of anxiety, constant internal tension, anxiety over trifles, irritability and impatience, decreased memory, concentration, absent-mindedness, learning difficulties, difficulty concentrating on tasks, decreased performance, and sleep disorders. It was established that the clinical picture of mental disorders in the examined patients is represented by depressive (29.1% of men and 32.1% of women), anxiety (31.4% and 33.4% respectively), astheno-neurotic (24.2% of men and 19.6% of women) and cognitive (15.3% and 14.9% respectively) syndromes. The examined patients are characterized by peaks on the scales of depression, anxiety, somatization, obsessive-compulsive, phobic anxiety and interpersonal sensitivity according to the Symptom Check List-90-Revised; the predominance of severe depressive and anxiety episodes and moderate depressive episodes according to The Hamilton Anxiety and Depression Scale; the dominance of high levels of situational and personal anxiety according to The State-Trait Anxiety Inventory; the presence of mild and moderate cognitive impairments according to the Montreal Cognitive Assessment and Mini-Mental State Examination; decrease in overall cognitive performance according to Addenbrooke’s cognitive examination.
Keywords: anxiety, depression, COVID-19, cognitive dysfunction.
References
Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737-54. DOI: 10.1080/23744235.2021.1924397. PMID: 34024217.
Legido-Quigley H, Asgari N, Teo YY, Leung GM, Oshitani H, Fukuda K, et al. Are high-performing health systems resilient against the COVID-19 epidemic? Lancet. 2020;395(10227):848-50. DOI: 10.1016/S0140-6736(20)30551-1. PMID: 32151326.
Coronavirus: statistics by countries. Minfin [Internet]. Available at: https://index.minfin.com.ua/ua/reference/coronavirus/geography [accessed 31 Dec 2024]. [In Ukrainian].
Cheng WJ, Shih HM, Su KP, Hsueh PR. Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders. Brain Behav Immun. 2023;114:255-61. DOI: 10.1016/j. bbi.2023.08.024. PMID: 37648008.
Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7(6):547-60. DOI: 10.1016/S2215-0366(20)30168-1. PMID: 32304649.
Mendelson M, Nel J, Blumberg L, Madhi SA, Dryden M, Stevens W, Venter FWD. Long-COVID: An evolving problem with an extensive impact. S Afr Med J. 2020;111(1):10-2. DOI: 10.7196/SAMJ.2020.v111i11.15433. PMID: 33403997.
Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. DOI: 10.1136/bmj.n136. Erratum in: BMJ. 2022;376:o126. DOI: 10.1136/bmj.o126. PMID: 33483331.
Zhou SJ, Zhang LG, Wang LL, Guo ZC, Wang JQ, Chen JC, et al. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19. Eur Child Adolesc Psychiatry. 2020;29(6):749-58. DOI: 10.1007/s00787-020-01541-4. PMID: 32363492.
Chaban OS, Khaustova OO. Mental health during the COVID-19 pandemic (features of psychological crisis, anxiety, fear and anxiety disorders): realities and prospects. NeuroNews. 2020;3(114):26-36. Available at: https://surl.li/rrhmly [in Ukrainian].
Mishchenko TS, Mishchenko VM. Neurological complications in patients with COVID-19. Psychiatry, Neurology and Medical Psychology. 2021;16:23-33. DOI: 10.26565/2312-5675-2021-16-03. [In Ukrainian].
Sher L. The impact of the COVID-19 pandemic on suicide rates. QJM: An International Journal of Medicine. 2020;113(10):707-12. DOI: 10.1093/qjmed/hcaa202. PMID: 32539153.
Maruta NO, Fedchenko VYu, Panko TV, Semikina OYe, Lapinska OR. Mental disorders in patients who have recovered from the coronavirus disease COVID-19, psychological aspect. Ukrainian Bulletin of Psychoneurology. 2023;31(2(115)):54-62. DOI: 10.36927/2079-0325-V31-is2-2023-7. [In Ukrainian].
Meaklim H, Saunders WJ, Byrne ML, Junge MF, Varma P, Finck WA, Jackson ML. Insomnia is a key risk factor for persistent anxiety and depressive symptoms: A 12-month longitudinal cohort study during the COVID-19 pandemic. J Affect Disord. 2023;322:52-62. DOI: 10.1016/j.jad.2022.11.021. PMID: 36372131.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.